Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Equity Average (2016 - 2025)

Historic Equity Average for Lemaitre Vascular (LMAT) over the last 15 years, with Q3 2025 value amounting to $370.8 million.

  • Lemaitre Vascular's Equity Average rose 1398.74% to $370.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $370.8 million, marking a year-over-year increase of 1398.74%. This contributed to the annual value of $317.6 million for FY2024, which is 1220.44% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Equity Average stood at $370.8 million, which was up 1398.74% from $355.1 million recorded in Q2 2025.
  • Lemaitre Vascular's Equity Average's 5-year high stood at $370.8 million during Q3 2025, with a 5-year trough of $175.0 million in Q1 2021.
  • Its 5-year average for Equity Average is $281.0 million, with a median of $279.0 million in 2023.
  • As far as peak fluctuations go, Lemaitre Vascular's Equity Average soared by 5085.94% in 2021, and later soared by 521.64% in 2022.
  • Over the past 5 years, Lemaitre Vascular's Equity Average (Quarter) stood at $251.6 million in 2021, then rose by 5.22% to $264.7 million in 2022, then increased by 10.78% to $293.3 million in 2023, then grew by 13.95% to $334.2 million in 2024, then increased by 10.96% to $370.8 million in 2025.
  • Its Equity Average was $370.8 million in Q3 2025, compared to $355.1 million in Q2 2025 and $342.4 million in Q1 2025.